Evidence map›Paper›PMID 38683394›Full record

ArticleArchives of gynecology and obstetrics2024

Comparing the effects of argon plasma coagulation and interferon therapy in patients with vaginal intraepithelial neoplasia: a single-center retrospective study.

Yuan Gao, Weixin Chu, Lin Hou, Junlan Cheng, Guyue Zhong, Baoguo Xia, Li Guo

Abstract readComparative Study
In one paragraph

Article in Archives of gynecology and obstetrics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Transvaginal flexible endoscopy for bleeding arteriovenous malformation hemostasis near a vesico-rectovaginal fistula.VideoGIE : an official video journal of the American Society for Gastrointestinal Endoscopy · 2025
    Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yuan GaoDepartment of Gynecology, Qingdao Municipal Hospital, Qingdao, Shandong, China.
Weixin ChuDepartment of Gynecology, Qingdao Municipal Hospital, Qingdao, Shandong, China.
Lin HouDepartment of Biochemistry and Molecular Biology, Basic Medical College, Qingdao University, Qingdao, Shandong, China.
Junlan ChengDepartment of Gynecology, The Second Affiliated Hospital of Shandong First Medical University, Taian, Shandong, China.
Guyue ZhongDepartment of Gynecology, Ansteel Group General Hospital, Anshan, Liaoning, China.
Baoguo Xia *Department of Gynecology, Qingdao Municipal Hospital, Qingdao, Shandong, China. xbgqd@126.com.
Li Guo *Department of Gynecology, Qingdao Municipal Hospital, Qingdao University, Qingdao, Shandong, China. guolislyy@163.com.ORCID 0000-0002-4653-5428

Funding

Natural Science Foundation of Shandong Province ZR2022QH074Shandong Medical and Health Science and Technology Development Plan 202105010641
6 · The paper itself

Abstract

purposeThis study aimed to evaluate the clinical efficacy and safety of argon plasma coagulation (APC) therapy and interferon therapy in patients with grade I and II vaginal intraepithelial neoplasia (VaIN).

methodsA total of 112 patients with VaIN were diagnosed via colposcopy-induced biopsy and classified into the APC group (n = 77) and interferon group (n = 35). Clinical data including age, grade, symptoms, historical or concomitant neoplasia of the lower genital tract, indications for hysterectomy, pregnancy history, cytology, human papillomavirus (HPV) subtype, treatment modalities, and clinical outcomes were analyzed, retrospectively. Complications and clinical outcomes were assessed at 6- and 12-month follow-ups.

resultsThere was no significant difference in the HPV clearance rate between the APC (53.42%) and interferon (33.33%) groups at 6 months after treatment. However, the 12-month follow-up of the APC group showed a significantly higher HPV clearance rate as compared to the interferon group (87.67% vs. 51.52%, P < 0.05). The APC group exhibited a significantly higher cure rate (79.22% vs. 40.0%) and lower persistence rate (12.99% vs. 37.14%) than the interferon group (P < 0.05). Adverse reaction analysis revealed that the primary reaction in the APC group was vaginal drainage, in contrast to the increased vaginal discharge in the interferon group; though the difference was significant (68.83% vs. 28.57%, P < 0.05), no serious complications were observed.

conclusionsTreatment with APC is a safe and more effective procedure against VaIN I and II, compared to interferon. APC may serve as a viable alternative to other physiotherapies.

Indexed as

Argon Plasma CoagulationCarcinoma in SituVaginal NeoplasmsAdultColposcopyCombined Modality TherapyFemaleHumansInterferonsMiddle AgedPapillomavirus InfectionsRetrospective StudiesTreatment OutcomeInterferonsArgon plasma coagulationEfficacyInterferonSafetyVaginal intraepithelial neoplasia

Identifiers

PMID38683394
PMCPMC11168973

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.